SYNGENE Trademark

Trademark Overview


On Thursday, August 16, 2018, a trademark application was filed for SYNGENE with the United States Patent and Trademark Office. The USPTO has given the SYNGENE trademark a serial number of 88981754. The federal status of this trademark filing is REGISTERED as of Tuesday, June 29, 2021. This trademark is owned by SYNGENE INTERNATIONAL LIMITED. The SYNGENE trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, large molecule development, antibody drug conjugates and clinical development services; consulting services in the field of medical practice management for others; business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business management consulting services in the field of pharmaceuticals drug development; none of the aforesaid services relating to gel imaging and gel analysis a...

Scientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, poly...
syngene

General Information


Serial Number88981754
Word MarkSYNGENE
Filing DateThursday, August 16, 2018
Status700 - REGISTERED
Status DateTuesday, June 29, 2021
Registration Number6405032
Registration DateTuesday, June 29, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 14, 2020

Trademark Statements


Description of MarkThe mark consists of the word "Syngene" in stylized font.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, large molecule development, antibody drug conjugates and clinical development services; consulting services in the field of medical practice management for others; business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business management consulting services in the field of pharmaceuticals drug development; none of the aforesaid services relating to gel imaging and gel analysis applications
Goods and ServicesScientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials; conducting clinical trials for scientific research for others; conducting clinical trials for pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; toxicokinetic analysis and toxicology services; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, genes, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applications, and none of the aforesaid services in the field of agriculture, horticulture and forestry

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, August 25, 2018
Primary Code035
First Use Anywhere DateTuesday, August 31, 2004
First Use In Commerce DateTuesday, August 31, 2004

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, August 25, 2018
Primary Code042
First Use Anywhere DateTuesday, August 31, 2004
First Use In Commerce DateTuesday, August 31, 2004

Trademark Owner History


Party NameSYNGENE INTERNATIONAL LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLink Rd, Bangalore Karnataka
IN

Party NameSYNGENE INTERNATIONAL LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLink Rd, Bangalore Karnataka
IN

Party NameSYNGENE INTERNATIONAL LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLink Rd, Bangalore Karnataka
IN

Trademark Events


Event DateEvent Description
Friday, June 2, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, June 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 2, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 29, 2021REGISTERED-PRINCIPAL REGISTER
Friday, May 28, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, May 27, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 26, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 6, 2021USE AMENDMENT FILED
Wednesday, May 26, 2021DIVISIONAL PROCESSING COMPLETE
Thursday, May 6, 2021DIVISIONAL REQUEST RECEIVED
Wednesday, May 26, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 6, 2021TEAS REQUEST TO DIVIDE RECEIVED
Thursday, May 6, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, March 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 1, 2021SOU EXTENSION 1 GRANTED
Monday, March 1, 2021SOU EXTENSION 1 FILED
Monday, March 1, 2021TEAS EXTENSION RECEIVED
Tuesday, September 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 23, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, June 26, 2020CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, June 24, 2020ASSIGNED TO PETITION STAFF
Tuesday, June 2, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, February 11, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 11, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2019NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2019NON-FINAL ACTION WRITTEN
Tuesday, June 4, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 6, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 6, 2018NON-FINAL ACTION E-MAILED
Thursday, December 6, 2018NON-FINAL ACTION WRITTEN
Monday, December 3, 2018ASSIGNED TO EXAMINER
Saturday, August 25, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 20, 2018NEW APPLICATION ENTERED